$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today

Natera (NASDAQ:NTRA) has outperformed the market over the past 5 years by 19.2% on an annualized basis producing an average annual return of 32.67%. Currently, Natera has a market capitalization of $1

Benzinga17:30 ET

Health Check: How Prudently Does Natera (NASDAQ:NTRA) Use Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor

Simply Wall St15:09 ET

Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

Yahoo FinanceJun 19 03:10 ET

Natera(NTRA.US) Officer Sells US$681.37K in Common Stock

$Natera(NTRA.US)$ Officer Chapman Steven Leonard sold 6,105 shares of common stock on Jun 17, 2024 at an average price of $111.6088 for a total value of $681.37K.Source: Announcement What is statement

moomoo NewsJun 18 22:16 ET

Form 144 | Natera(NTRA.US) Officer Proposes to Sell 681.37K in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 17, $Natera(NTRA.US)$ Officer STEVEN L CHAPMAN intends to sell 6,105 shares of its common stock on Jun 17, with a total market value of approximately $681.37K. STEVEN L C

moomoo NewsJun 17 16:39 ET

Natera Launches Differentiated New Feature for Prospera Heart Test, Enhancing Detection of Rejection for Transplant Patients

Donor Quantity Score (DQS) technique is unique to Natera, improving detection of both acute cellular rejection and antibody-mediated rejection Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA (cfDNA) and

BusinesswireJun 17 07:00 ET